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INTRODUCTION
The lymph node is one of the major anatomic components of the immune system. 
Lymph  nodes  are  the  most  widely  distributed  and  easily  accessible  component  of 
lymphoid  tissue  and  hence  they  are  frequently  examined  for  diagnosis  of 
lymphoreticular disorders.
Diagnosis  of  lymphadenopathy  depends  mainly  on  excision  of  a  gland  and 
histopathological  examination.  For  this,  general  anaesthesia  and  hospitalisation  are 
required.  Fine  needle  aspiration  cytology,  on  the  other  hand,  is  free  from  these 
disadvantages and can safely be used as an alternative or complementary investigative 
technique.
Anatomy:  
Lymph nodes are organized collections of lymphoreticular tissue in the form of 
pink  gray,  kidney  shaped,  encapsulated  organs.   They  are  located  at  anatomically 
constant points along the course of lymphatic vessels.  The common sites of distribution 
for clinical consideration are the cervical, axillary, supraclavicular and inguinal regions.
Histology:
The lymph node consists of lymphocyte aggregations, intermeshed with lymphatic 
sinuses  supported  by  reticular  fibre  framework and surrounded by connective  tissue 
capsule.
The lymph node has cortex, para cortex, and medulla.
The cortex is situated beneath the capsule and contains large number of follicles. 
The medulla close to the hilum is rich in lymph sinuses, arteries, and veins but contains 
only a minor lymphocytic component. Both cortex and medulla represent ‘B’zones.  The 
cortex contains primary and secondary follicles, which are characterized by the presence 
of central pale area of germinal centers.  The cells present in these formations are B-
lymphocytes  known as  follicular  center  cells  (centroblasts,  centrocytes  or  small  and 
large  cleaved  and  noncleaved  cells),  macrophages,  and  follicular  dentritic  cells.   A 
mantle of dark staining small B-lymphocytes surrounds the germinal centre.  The para 
cortex is the zone situated between the cortex and medulla which contains the mobile 
pool of T lymphocytes50
Development:
In human embryo, the lymph sacs from which the lymph vessels are derived are 
six in number. 2 paired (jugular and the posterior lymph sacs) and two unpaired (the 
retroperitoneal and cysterna chyli).  From the lymph sacs, the lymph vessels bud out 
along lines  corresponding more  or  less  closely  with  the course  of  embryonic  blood 
vessels, most commonly veins.
All  the lymph sacs except  the cysterna chyli  are at  a  later  stage divided by a 
number  of  slender  connective  tissue  bridges;  subsequently  they  are  invaded  by 
lymphocytes and transformed into groups of lymph nodes.
Fine needle aspiration cytology of lymph node:
A normal lymph node is rarely palpable.  Cytological characteristics of cells from 
a normal lymph node are essentially based on the morphology of individual cells as 
observed in the aspirate from a reactive lymph node.  The lymphocytes constitute 87% 
to 99%, Plasma cells 0% to 5% and remainder cells (histiocytes, mast cells, eosinophils 
and neutrophils) 1% to3%.
AIM OF STUDY
• To statistically evaluate the incidence of lymph node lesions.
• To assess the usefulness of the cytological study in the diagnosis of lymph node 
lesions.
• To evaluate the accuracy of FNAC studies in correlation with histopathological 
study.
• To compare the sensitivity, specificity and accuracy with previous studies 
conducted at other centres.
• To determine and evaluate the causes for false positivity and negativity and to 
arrive at possible suggestions to minimize the percentage, in this regard.
REVIEW OF LITERATURE
Grieg  and Gray36 used  aspiration of  lymph nodes  as  early  as  in  1904 for  the 
diagnosis of sleeping sickness by recognizing mobile trypanosomes. 
Guthrie in 192142  compiled one of the earliest series on aspiration biopsy from 
cervical  lymphadenopathy,  describing  cell  specimens from lymphadenitis,  metastatic 
carcinoma, and Hodgkin’s disease.  Forkner32 in 1927 studied node punctures from 30 
patients, and Martin and Ellis80 in 1930 aspirated from lymph nodes in 23 cases.
FNA biopsy rarely interferes significantly with histological interpretation5.  FNA 
biopsy can be useful to obtain material for culture, because a specific diagnosis can lead 
to specific therapy.65 
Normal lymph node and reactions:
Ninety-five percent of the cells found in FNA biopsy specimens of normal lymph 
nodes are Lymphocytes in which small, mature lymphocytes normally compose about 
67% to 90% of the cells,  immature lymphocytes about 5% to 16%.  Histiocytes and 
monocytes comprise less than 8%. Mast  cells are sparse  in the normal lymph node, 
about 0.1% of the cells.  Neutrophils comprises 0% to 2.2% of cells, Plasma cells are 0% 
to 5%. Eosinophils are about 0% to 0.3%. Basophils comprise about 0% to 0.2% of the 
cells.73 
Cyto diagnosis of lymph node aspirate can be grouped as:78
1. Lymphadenitis and hyperplasia
2. Lymphomas and Leukemias
3. Metastatic neoplasms
Lymphadenitis and hyperplasia:
Depending on the type of  stimulus,  a  node may react  with one of  three basic 
histological and cytological patterns:
1. Reactive hyperplasia
2. Suppurative lymphadenitis
3. Granulomatous lymphadenitis
Reactive hyperplasia
The causes of reactive lymphoid hyperplasia would make a long list of bacteria, 
viruses,  chemical,  environmental  pollutants,  drugs,  altered  tissue  components,  and 
numerous other substances acting as antigens or allergens.  Most enlarged lymph nodes 
involved  by  reactive  lymphoid  hyperplasia  or  atypical  lymphoid  hyperplasia  do  not 
exhibit morphologic patterns indicative of specific agents,  and therefore the cause of 
reactive lymphoid hyperplasia is listed as unknown.
Cytology:
High  cell  density,  polymorphic  cytological  pattern,  and  tingible  body 
macrophages (TBM) are the three important characteristics of follicular hyperplasia.114
Follicular Center Fragments represent intact or fragmented lymph node follicles,87 
the presence of all  three components in the follicular  center fragment (i.e.,  range of 
maturation,  tingiblebody  macrophages,  lymphohistiocytic  aggregates)  generally 
indicates a benign, reactive lymphoid process. 
Although similar fragments can be seen in lymphoma, they are usually missing at 
least one element, e.g., tingiblebody macrophages. In addition, the presence of follicular 
center fragments does not exclude Hodgkin's disease or metastasis.
However,  any  high-grade  lymphoma  can  have  tingiblebody  macrophages.  In 
addition,  lymph nodes  harboring  metastatic  tumor,  Hodgkin's  disease,  or  those  only 
partially involved by lymphoma may have tingiblebody macrophages on FNA biopsy.
 On the other  hand,  tingiblebody macrophages (TBM) may be rare  in benign, 
indolent lymph nodes. Therefore, the mere presence of TBMs does not guarantee that a 
lymph node FNA biopsy is benign. Moreover, the absence of tingiblebody macrophages 
does not necessarily mean the aspirate is malignant.
Lymphohistiocytic aggregates are also a common feature of benign lymph node 
aspirates, found in up to three quarters of cases. Lymphohistiocytic aggregates are often 
indicating follicular center formation, but it can also be seen in sinus histiocytosis or 
medullary cord expansion.
 Lymphohistiocytic  aggregates  are  also  common  in  aspirates  of  follicular 
hyperplasia and they are thought to be markers of follicle formation.87 
However, a diagnosis of reactive hyperplasia, or chronic lymphadenitis, does not 
necessarily exclude the possibility of metastatic  carcinoma,  granuloma,  or  Hodgkin's 
disease, all of which can occur in a reactive background.39
In the absence of characteristic cells (malignant, epithelioid, or Reed-Sternberg), 
the cytologic diagnosis would be largely descriptive. 
Histopathology:
Most benign, inflammatory hyperplasia are seen in youth.67 
Lymphadenitis and lymphadenopathies tend to exhibit one of four characteristic 
histologic patterns: follicular, sinus, diffuse, or mixed.26 These  represent  expansion  of 
the normal follicular, paracortical, medullary and sinusoidal lymph node compartments.
The sinus pattern is  particularly  noticeable  in  sinus histiocytosis  with massive 
lymphadenopathy and in lymph nodes draining malignant tumors.
In  Diffuse  Pattern,  the  entire  lymph  node  parenchyma  consists  of  sheets  of 
lymphocytes  admixed  with  immunoblasts  and  occasional  macrophages.  Diffuse 
immunoblastic,  Para  cortical  hyperplasia  is  caused  by  certain  viral  infections, 
particularly infectious mononucleosis, vaccinations, drug reactions (classically Dilantin) 
and also seen in some autoimmune diseases, such as systemic lupus erythematosus.107
Important clues of benign lymphadenopathy  include the presence of plasma cells, 
in different stages of maturation and immunoblasts, together with other lymphoid cells 
and histiocytes, without obvious signs of anaplasia.127
The reactive  follicles  do  not  infiltrate  the surrounding adipose  tissues  largely, 
even when highly stimulated.
Suppurative lymphadenitis:
 In the initial phase, mixture of lymphocytes and neutrophils may be seen in the 
smear; in the florid state the smear contains both well-preserved as well as degenerated 
neutrophils and cell debris. With organization of the inflammatory exudates, especially 
in the antibiotic treated cases, the smear contains polymorphs, lymphocytes, plasma cells 
and histiocytes along with cell debris.
Granulomatous lymphadenitis:
Tuberculosis: 
Cytology:
Nodular  collections  of  epithelioid  histiocytes  with  Langhans'  giant  cells  and 
caseous necrosis are most characteristic in FNAC.2 However, occasionaly, granulomas 
without necrosis or conversely only necrosis, without epithelioid or giant cells may be 
aspirated.18
Aspirated granulomas may form acellular, homogeneous, eosinophilic structures 
with irregular shapes and well-defined edges.91 
Aspirated material can also be cultured to help make the specific diagnosis of 
tuberculous lymphadenitis.99
 
Mycobacteria cannot be seen in Diff-Quik, Papanicolaou, Gram stain and it  is 
most likely to be demonstrable by using acid fast or auramine-rhodamine stains in the 
necrotic material.38
Lau S-K et al (1991)64 stated that the combined use of tuberculin skin testing and 
FNA biopsy are complementary and efficient in the diagnosis of tuberculosis. 
Histopathology:
The  appearance  ranges  from  multiple  small  epithelioid  granulomas  to  huge 
caseous masses surrounded by Langhans’ giant cells, epithelioid cells and lymphocytes.
Monocytoid  B  cells  may  play  a  role  in  recruitment  of  neutrophils  and 
development of necrosis in Chronic Granulomatous Disease.30
Giant cells are not normally present in lymph nodes but it can be seen in a wide 
variety of benign and malignant conditions. Benign giant cells are associated with acute, 
chronic or granulomatous lymphadenitis. Malignant giant cells are associated with T-
cell  lymphoma,  anaplastic  large  cell  lymphoma  (T  or  B),  Hodgkin's  disease  and 
metastasis.102
The epithelioid histiocytes may proliferate to the point of mimicking a neoplasm 
(spindle cell pseudo tumor).15
 Granulomas can be seen in Hodgkin's disease, T cell non-Hodgkin's lymphoma 
and some carcinomas, particularly with squamous differentiation.90
Martelli G (1989)79 stressed that in a clinically suspected case, especially if the 
aspirate contains pus, a bacteriological examination should be tested for acid-fast bacilli 
and a culture made to improve the diagnostic accuracy. 
FNAC is a reliable diagnostic tool in helping to avert the more invasive surgical 
procedures undertaken in the diagnosis of tuberculous adenitis. 
The  success  result  of  FNAC  in  tuberculous  lymphadenitis  was  80%  (Bloch 
1967)10 87.18% (Patra et al 1983)93and 83.33% (Dandapat et al 1986)17
Bezabih M et al (2003)9  studied 880 patients presenting with enlarged superficial 
lymph nodes and pointed that among the benign lesions  the most frequent cause of 
lymph node enlargement was tuberculous lymphadenitis (66.3%), followed by reactive 
hyperplasia (19.2%).
FNA biopsy  can  play  an  important  role  in  evaluation,  including  diagnosis  of 
opportunistic  infections,  Kaposi's  sarcoma  and  lymphoproliferative  lesions  such  as 
persistent generalized lymphadenopathy and lymphomas.11 
Lymphomas:
Lymphomas  are  classified  broadly  into  Hodgkin’s  Lymphoma and  Non-
Hodgkin’s Lymphoma.  There are malignant proliferations of lymphoid cells, which are 
normally found in lymphoid organs such as lymph nodes, tonsils, spleen and thymus 
gland.   In addition, lymphomas may arise in every other type of organ such as the brain 
or stomach and these are termed extra-nodal lymphomas.
Non-Hodgkin’s Lymphoma:
Rappaport(1966)101  published  classification  of  Non-Hodgkin’s  Lymphoma 
according to tissue architectural pattern and cytologic findings.
 In 1970s, Lukes and Collins75, 76 deemphasized growth pattern and introduced the 
immunologic concepts of B and T cells. 
The Kiel classification is based entirely on cytological criteria68   hence, it can be 
directly applied to cytological biopsy material.89
 Working Formulation was proposed in the 1980s, in an attempt to overcome the 
diagnostic chaos caused by so many different classification systems.69, 83 
According to Working Formulation Non Hodgkin Lymphomas are classified into 
low, intermediate and high grade based only on morphologic appearance and not on 
immunology.  Realizing  the  limitations  of  cytology  in  the  diagnosis  of  histologic 
characteristics such as nodularity, the grouping of the various cytologic types of NHL 
has been slightly modified.
REAL system (1994) categorizes entities based on the neoplasm’s cell of origin. 
The new WHO classification for lymphomas is similar to the REAL system with minor 
modification.
 Half of the patients with NHL are in their fifties to sixties. NHL more frequently 
affects men than women.
Cytology:
FNA  biopsy  should  be  the  first  line  of  morphologic  investigation  of 
lymphadenopathy.19  
The  diagnosis  of  lymphoma  can  actually  be  easier  with  cytologic  than  with 
histological studies (single cell pattern, lympho glandular bodies, enhanced cytological 
detail).127
 In addition in some cases, the cytologist rather than the histologist may be better 
able to sub classify malignant neoplasm of the lymphoreticular system.10 
The diagnosis of lymphoma particularly non-Hodgkin's type, by FNAC should be 
usually confirmed before therapy. Methods of confirmation depend on the individual 
diagnosis and can include examination of the peripheral blood, bone marrow, serum and 
urine proteins.
 Usually, a tissue biopsy is obtained for histologic classification and verification of 
a primary cytological diagnosis of lymphoma.33 
The diagnosis of low-grade lymphomas can sometimes be difficult, particularly 
for those that have a conspicuous nonmalignant component.115
There  may  be  a  diagnostic  gray  zone  between  low  and  intermediate  grade 
lymphomas,  because  architectural  growth  pattern  usually  cannot  be  assessed 
cytologically.120 
Cytodiagnosis is particularly important in patients who are in poor surgical risks, 
in whom an abnormal superficial lymph node is unavailable for tissue biopsy102  and if 
the only accessible node is in a location that makes excisional biopsy hazardous, e.g., 
directly on an important nerve.72 
Reactive lymphadenopathy is the most likely benign process to be interpreted as 
malignant.100
 On the  other  hand,  if  a  lymphoma is  mistakenly  considered  to  be  a  benign, 
reactive process  it will not follow a typical, benign clinical course or   significantly 
respond to medical therapy.97
 False-negative results are usually  as the result  of inadequate sampling due to 
small or inaccessible nodes, fibrosis, necrosis, or small cell lymphomas, or sampling the 
wrong node.105 
In some cases of lymphoma, the clinical signs and symptoms may be misleading, 
suggesting some other disease. FNA biopsy can help point to the correct diagnosis.102
A  dispersed  population  of  single  cells  and  lymphoglandular  bodies  that  can 
sometimes make the diagnosis of lymphoma is more obvious in cytologic than histologic 
studies.98
When  confronted  with  a  poorly  differentiated  neoplasm,  the  diagnosis  of 
lymphoma can actually be easier with cytologic than with histologic studies.127   
If the FNA biopsy is obtained to document recurrence or for staging of known 
disease,  i.e.,  secondary  diagnosis,  then  the  cytologic  diagnosis  alone  is  generally 
sufficient. 
Secondary diagnosis of lymphoma are usually easy, accurate and reliable and may 
obviate open biopsy.98 
FNA  biopsy  can  usually  distinguish  between  low-grade  and  high-grade  non-
Hodgkin's lymphomas.22
 Cytologic studies can be useful for documenting transformation to a higher-grade 
malignancy as may be encountered in cases like Richter syndrome.
 FNA biopsy is also useful in obtaining diagnostic material for special studies such 
as flow cytometry, electron microscopy, immunocytochemistry, molecular cytogenetics, 
gene rearrangement, polymerase chain reaction or research.119 
Berard et al 7 (1981) pointed that monoclonality usually indicates malignancy and 
polyclonality favors a benign lesion.
Epstein-Barr  virus  may also play  a  role  in  the development  of  non-Hodgkin's 
lymphomas in a proportion of HIV-infected patients. In HIV patients, most lymphomas 
are non-Hodgkin's and usually high grade such                          as small noncleaved or 
large cell immunoblastic.37 
Low-grade, small cell, or mixed lymphomas and lymphomas confined to follicles 
or only partially involving a node are more difficult to recognize and subclassify with 
cytologic studies, often mimicking reactive lymphadenopathy.126 
FNA biopsy  can  usually  diagnose  high-grade  Non-Hodgkin's  lymphomas  and 
most cases of Hodgkin's disease. Diagnosis of low-grade lymphomas can sometimes be 
difficult, particularly for those that have a conspicuous nonmalignant component.96
Occasionally,  vague  dense  aggregates  of  lymphoma  cells,  apparently 
corresponding to follicles, suggest follicular differentiation in FNA biopsy specimens.89  
The FNA biopsy of  lymphoblastic lymphoma consists,  in essence of numerous 
blasts with frequent mitoses.52 
The  smear  of  small  lymphocytic  lymphoma  is  composed  of  monotonous 
population  of  lymphoid  cells,  the  cells  have  scanty  light  blue  cytoplasm and round 
nuclei with multiple coarse chromatin. Mitotic activity is rare.
FNA Biopsy  of  Large  cell  lymphoma shows  predominantly  noncleaved  large 
cells.
The  aspirate  of  Lymphoplasmacytic  lymphoma is  similar  to  ordinary  small 
lymphocytic lymphoma, except that many lymphocytes are plasmacytoid.20 
In  Small Cleaved cell  Lymphoma the most characteristic feature is the cleaved 
nucleus which is irregular and markedly indented with deep folds.
The nuclei of Burkitt's lymphoma are round to oval and occasionally multiple. The 
nuclear  membrane  is  generally  smooth  (ie,  noncleaved),  but  may  be  notched  or 
indented.21 
The FNA biopsy specimen of Mycosis Fungoides shows a variable mixture of 
atypical  small  and  large  lymphoid  cells  plus  a  reactive  component  of  eosinophils, 
plasma  cells,  and  nonneoplastic  lymphocytes.  The  small  cells  have  small, 
hyperchromatic  nuclei  and  inconspicuous  nucleoli.  As  the  disease  progresses,  large 
lymphoid  cells  with  pale,  vesicular  nuclei  and  prominent  nucleoli  become  more 
numerous.130 
The aspirate of T-cell lymphomas are usually cellular, unless fibrosis is prominent 
and is characterized by cellular polymorphism.53
The FNA biopsy of  Anaplastic Large Cell Lymphoma shows large pleomorphic 
cells, which range in appearance from immunoblast-like to bizarre and anaplastic.120 
Histopathology:
The morphologic appearance of a lymphoma depends on the infiltration of normal 
structures, the host immune response and reactive changes that result from secretion of 
cytokines, all of which can vary from site to site, patient to patient and tumor to tumor. 
Small lymphocytic lymphoma constitutes only 4% of NHL. It occurs in late adult 
life peaking in the sixth or seventh decade.
 Up to 70% of patients with small lymphocytic lymphoma have leukemia (chronic 
lymphocytic leukemia, CLL) or an absolute lymphocytosis (>4,000/mm3).92 
In  Small  lymphocytic  lymphoma,  most  of  the cells  (>80%) resemble ordinary 
small  lymphocytes,  except  that  they  are  often  slightly  larger  than  normal  and  the 
chromatin is not quite as dense.103 
These  cells  are  mixed  with  variable  numbers  of  larger  cells  called 
prolymphocytes.  In  many  areas  prolymphocytes  gather  together  focally  to  form 
proliferation centers. 
In some cases of small lymphocytic lymphoma the chromatin is clotted (cellules 
grumelées, cells with little clots) and resembles exaggerated clock face chromatin of 
plasma cells.113 
small  lymphocytic  lymphoma cells  are  small  and  the  nuclear  membranes  are 
smooth except for the rare T-cell type.71
Immunohisto  chemistry  for Small  Lymphocytic  Lymphoma  were  B  cell 
phenotype,  Monoclonal  surface  Igs  (low  density),  CD5+,  CD10-,  CD19+,  CD20+, 
CD23+, FMC7-,bcl-1 protein-, bcl-2 protein +.
In the diffuse variant of  Small Cleaved cell Lymphoma, the chromatin may be 
relatively delicate or blastoid and the cytoplasm are scant, but may be slightly more 
abundant than in a small lymphocyte, azurophilic granules can be seen in a few cases in 
Diff-Quik. Mitoses are usually rare.60 
45% of adult lymphomas are Follicular lymphoma, it usually presents in middle 
age and afflicts males and females equally.
 Follicular lymphoma tends to progress with time to a diffuse pattern and larger 
cell type.44
Dendritic reticulum cells or lymphohistiocytic aggregates are usually present and 
often abundant in  follicular lymphomas whereas, these are only occasionally seen in 
diffuse lymphomas.61 
The presence of follicular  center fragments or  dendritic  reticulum cells,  which 
apparently correspond to lymphohistiocytic aggregates are more commonly present and 
more abundant in follicular than diffuse NHL.61 
Certain lymphomas,  such as follicular center cell  lymphomas and many T-cell 
lymphomas, including lymphoblastic can show marked pleomorphism.127
Approximately 60% to 70% of the cases of Follicular center lymphoma have bone 
marrow involvement at the time of diagnosis. 
Follicular lymphoma is generally associated with a better prognosis than diffuse 
lymphoma of the same cell type.131 
Immunohisto  chemistry  for Follicular  lymphoma   are  CD5-  CD10+,  CD19+, 
CD23- ,CD43-,CD79a+,Monoclonal sIg+
The two main cell types of large cell lymphomas are centroblastic and 
immunoblastic as in the Kiel classification.108 
The  prognosis  of  both  follicular  and  diffuse  lymphomas  correlates  with  the 
proportion of small and large cells. The more small cells have better prognosis, the more 
large cells have the worse prognosis.101 
Lymphoplasmacytic lymphoma is morphologically and clinically similar to small 
lymphocytic lymphoma, except for the presence of plasmacytoid lymphocytes and the 
more common occurrence of a monoclonal gammopathy. 
Intracytoplasmic (Russell) bodies and intranuclear (Dutcher) bodies, composed of 
immunoglobulin are highly characteristic of Lympho plasmacytic lymphoma if present, 
but they are not diagnostic features.60 
 Immunohisto chemistry for Lymphoplasmacytic lymphoma  were CD5-CD10-
CD19+, CD20+, CD23- ,Monoclonal surface IgM+.
The cells of Burkitt's  lymphoma are cytologically indistinguishable from acute 
lymphoblastic leukemia, FAB-L3.56
Morphologic findings alone cannot reliably determine whether a lymphoma is of 
B or T cell origin,102 but can differentiate Burkitt’s and non-Burkitt's lymphomas.
Lennert's  lymphoma is  the  occurrence  of  numerous  epithelioid  histiocytes  but 
usually not well-formed, sarcoid-like granulomas.94
Mixed lymphoma is a "mixed bag" of diseases characterized by heterogeneous 
cell morphologies and cell types.123 
The immunologic studies of  Mixed Lymphoma have shown that  most  (~70%) 
cases are of B-cell origin, about 20% are T cell, 10% Null cell and less than 5% are true 
histiocytes.132 
Most  cases  of  lymphoblastic  lymphoma  show  T  cell  phenotype,  but  a  small 
proportion of cases expresses  Precursor-B or B-cell phenotypes.16
Proliferative activity of cells also correlates with grade in general; the higher the 
mitotic count, the higher is the grade of the lymphoma102
 Dividing the cells into small, medium, and large size groups correlates, to some 
extent with low, intermediate and high-grade lymphoma.104
In low-grade lymphomas, most cells (50%- 80%) are small with relatively few 
large cells.109 
Intermediate  lymphocytic  lymphoma  shares  many  features  with  small 
lymphocytic lymphoma and small cleaved lymphoma, the diseases are closely related.117
 In Intermediate lymphocytic lymphoma, most of the cells are small to medium 
sized lymphocytes with slightly irregular nuclear contours, the chromatin is less coarse 
than that of normal lymphocytes and occasionally is fine. Nucleoli are distinct and like 
prolymphocytes, may be surrounded by a rim of chromatin .60 
The  demonstration  of  a  dominant  or  abnormal  T-cell  phenotype  in 
morphologically atypical cells suggests T-cell malignancy.111
A  characteristic  feature  of Adult  HTLV-Associated  T-Cell  Lymphoma  is  the 
presence of highly pleomorphic, lobulated (flower-like) lymphoid cells in the blood.102 
Elavathi et al (1989)28 described multilobated nuclei in one variant of T-cell lymphomas. 
In T-cell lymphomas, cytoplasm varies from scant to relatively abundant and may 
contain fine granules,88 lymphoglandular bodies may be sparse or absent. 
The  cells  of  Anaplastic  Large  Cell  Lymphoma are  predominantly  single,  but 
occasional clustering may suggest an epithelial malignancy4. 
The nuclei of Anaplastic Large Cell Lymphoma are large, frequently indented or 
lobulated with granular chromatin and one or more conspicuous nucleoli.88 
Anaplastic  Large  Cell  (Ki-1,  CD30)  Lymphoma  is usually  of  T-cell  origin, 
although markers are heterogenous and include B cell, Monocytic, and Null cells.95 
  
Immunophenotyping or genotyping is usually required to confirm T-cell origin, in 
contrast  with  B-cell  lymphomas,  in  which  morphologic  appearance  alone  is  often 
sufficient.59 
The correlation of cytologic with histologic studies, immunology, and cytometry 
is excellent.3
Composite  lymphoma  refers  to  the  coexistence  of  two  distinct  types  of  Non-
Hodgkin's lymphoma or rarely, NHL and Hodgkin's disease, in a single organ or tissue.31
Discordant lymphoma is the occurrence of two different types of lymphoma at 
separate anatomic sites.
  
 The prognosis depends on the higher-grade lymphoma, even though the low-
grade lymphoma may be disseminated.55 
The incidence of bone marrow involvement is higher in low-grade lymphomas 
than in many of the high-grade lymphoma.23
Lopes Cardozo P (1980)71 stated that in fresh cases of lymphoma surgical biopsies 
should always be done, whereas in relapses cytology alone will be sufficient. 
Gupta et al (1977)41 and Tripathi et al (1985)121 quoted the diagnostic accuracy of 
lymphoma as 84% and 80% respectively.
Nasuti JF, et al (2000)84 observed 387 cases of FNAC of lymph node over a 5-year 
period.  In their study, they diagnosed successfully 61 cases of lymphoma via FNAC 
with no false positives. 
Hodgkin’s Lymphoma:
Classification:
In 1944 Jackson and Parker47 divided Hodgkin’s Lymphoma into three subtypes-
paragranuloma, granuloma and sarcoma.
Lukes  and  Butler  in  1966,74 classified  Hodgkin’s  Lymphoma  in  to  six  types, 
shortly  afterward  at  the  Rye  conference  this  was  simplified  into  four  subtypes  as 
Lymphocyte  predominance,  Nodular  sclerosis,  Mixed  cellularity  and  Lymphocyte 
depletion.
In 1994 REAL classification and with further modification by WHO Hodgkin’s 
Lymphoma is divided into two major entities, as lymphocyte predominance and classic. 
Classic  type  is  further  subdivided  into  Nodular  sclerosis,  Lymphocyte  rich,  Mixed 
cellularity and Lymphocyte depletion. 
Cytology:
Hodgkin’s  Lymphoma  accounts  for  approximately  20%  of  newly  diagnosed 
lymphomas.   FNAC  has  an  important  but  limited  role  in  the  initial  diagnosis  of 
Hodgkin’s  Lymphoma.133 However,  FNAC  is  very  useful  in  diagnosing  recurrent 
disease.19  
Reed  Sternberg  cells  (RS)  are  essential  in  the  primary  diagnosis  of  Hodgkin 
Lymphoma.  Lacunar  cells  are  unusually  large  variants  of  RS  cells  with  abundant 
cytoplasm, which are a characteristic feature of nodular sclerosis Hodgkin’s disease.74 
However lacunar cells are seen in other types of HD particularly mixed cellularity.14
RS-like cells can be seen in other diseases, so the RS cells must be found in the 
characteristic background, i.e., in the proper milieu to diagnose Hodgkin’s disease.118
Bizarre, Reed-Sternberg-like cells can occur occasionally, in CLL/SLL.108
In Lymphocyte-predominant Hodgkin's disease, the predominant cells are small, 
mature and activated (T) lymphocytes. Classic Reed-Sternberg (RS) cells are rare.86  
 Reed-Sternberg cells and variants are usually easy to find in Mixed Cellularity 
Hodgkin's Disease.
 Pleomorphic R.S cells are relatively abundant and nonneoplastic lymphoid cells 
are sparse in Lymphocyte-depleted Hodgkin's disease.102 
    
The ratio of neoplastic to reactive cells is of primary importance in classifying the 
subtype of Hodgkin's disease.3
Benign,  reactive  lymphoid  cells,  plasmacytoid  cells,  plasma  cells,  histiocytes, 
granulomas, metachromatic fibrillar material, eosinophils, neutrophils and necrosis may 
all be seen in the background of Hodgkin's disease and in cases of recurrent Hodgkin's 
disease, which progressed rapidly despite therapy.34 
 Rarely,  neutrophils,  histiocytes  and  necrosis  mimicking  suppurative 
lymphadenitis or an abscess dominates the background.35 
Gupta  et  al  (1977)41 demonstrated  the  possibility  of  overlap  among  reactive 
hyperplasia,  lymphocytic  lymphoma  and  Hodgkin’s  disease  in  aspiration  smears  of 
lymphoma cases 
The  cytologic  studies  of  Lymphomatoid  Granulomatosis show  a  mixed 
inflammatory infiltrate, including atypical lymphocytes, some with Reed-Sternberg-like 
features, in a granulomatous background with numerous giant cells.128 Granulomatous 
inflammation is a good prognostic sign in   Hodgkin's disease.106 
FNA biopsy is adequate to evaluate the stage of the disease, assess the therapeutic 
response and document recurrence in Hodgkin’s disease.24 
Histopathology:
Hodgkin's  disease  (HD)  primarily  involves  lymph  nodes.  It  arises  in  a  single 
lymph node or group of nodes and characteristically tends to spread in contiguity from 
group to group.51 
Hodgkin’s disease has bimodal age distribution with first peak between 15 and 34 
years and the second peak after 54 years.77
 Men are somewhat more commonly affected than women (4:3) and also have a 
worse prognosis. Half of the patients are between the ages of 20 and 40. Less than 10% 
are younger than 10 years or older than 60 years.
Cervical  lymph nodes  are  by  far  the most  common primary  site,  followed by 
mediastinal and then axillary nodes.
Unlike Non-Hodgkin's lymphoma, HD virtually never presents in an extranodal 
site although later it can disseminate.102
Hodgkin's  disease  is  curable,  especially  when  low  stage.  The  overall  3-year 
survival rate is better than 80%.54
The ratio of neoplastic to reactive cells is of primary importance in classifying the 
subtype of HD3. When neoplastic cells, including RS cells and their variants are rare, 
as in lymphocyte predominant HD the prognosis is better. 
When neoplastic cells are numerous, as in lymphocyte depleted HD the prognosis 
is worse. Mixed cellularity is intermediate.3
For the diagnosis of Nodular sclerosis Hodgkin’s Lymphoma, a minimum of a 
single polarizable fibrous band is required.
 
The  presence  of  a  nodular  sclerosing  stromal  reaction  is  associated  with  a 
favorable prognosis.
Two types of Lymphocyte depletion Hodgkin’s Lymphoma are diffuse fibrosis 
type and reticular type.
 
Reactive  lymphadenopathy  due  to  viral  infection,  infectious  mononucleosis, 
Toxoplasmosis and drug hypersensitivity reaction (eg, to hydantoin) are among the most 
common benign entities to be mistaken for Hodgkin's disease.112 
Occasionally lacunar cells form syncytial clusters (syncytial variant), which may 
suggest  large  cell  non-Hodgkin's  lymphoma  or  poorly  differentiated  carcinoma, 
sarcoma, melanoma, thymoma or germ cell tumors6
The  incidence  of  bone  marrow  involvement  in  Hodgkin’s  lymphoma  is 
approximately 10% in classical Hodgkin’s mixed cellularity type and 1% in lymphocyte 
predominant  Hodgkin’s  and  lymphocyte  rich  classical  Hodgkin’s  disease.   Nodular 
sclerosis has an incidence of 3%.82 
Singh MK et al (1988)110 pointed out that in the diagnosis of lymphoma, false-
negative cases tend to be more common and are generally based on sampling rather than 
diagnostic errors such as the absence of Reed-Sternberg cells which are important in the 
diagnosis of Hodgkin’s disease.
Jimenez-  Heffernan JA et  al  (2001)49 evaluated cytodiagnosis  of  170 cases of 
Hodgkin’s Diseases with the final histopathological report. The sensitivity found in this 
series was 82.4%. The positive predictive value was 91.2%  
Leukemia:
Cytology:
 
Lymphadenopathy is commonly present in patients with leukemia. Any category 
of leukemia including lymphoid, myeloid and monocytic can cause lymphadenopathy.
Enlargement  of  lymph  nodes  occur  most  commonly  in  the  course  of  Acute 
leukaemias.
Lymphadenopathy is present in 50% patients with Acute myeloid leukemia, 50% 
of  patients  with  Acute  monocytic  leukemia  and  80%  of  patients  with  Acute 
lymphoblastic leukemia.
Dunphy (1989) pointed out that FNA biopsy is useful in the diagnosis of leukemic 
lymphadenopathy.27 
In  the  FNA  biopsy  of  lymphoblastic  lymphoma,  the  cells  are 
indistinguishable from the lymphoblasts and prolymphocytes that are characteristic of 
acute lymphoblastic leukemia (ALL).
In cases of Acute myeloblastic leukaemia with lymphadenopathy, the FNA biopsy 
specimen is characterized by myeloid cells in various stages of maturation, the cytologic 
findings depend on the degree of differentiation. The presence of Auer rods supports the 
diagnosis.63
Cytochemical  stains,  eg,  chloroacetate  esterase,  sudan  black,  and 
myeloperoxidase may be helpful in cases dominated by blasts.129
.
In FNAC of a leukemic infiltrate in bloody smears, the malignant cells could be 
contaminants from the blood.102
Histopathology:
Nodal architecture may be partially or completely effaced in myeloid leukemia.
Prominent infiltrates are seen in the medullary and paracortical areas of nodes. In 
some  cases,  eosinophilic  myelocytes  are  indicators  of  the  leukemic  nature  of  the 
infiltrate.85 
Some of  the case show prominent  megakaryocytic  differentiation and may be 
confused with Hodgkin’s disease.
In  Lymphoid  leukemia  nodal  architecture  is  usually  effaced  by  infiltrates  of 
primitive cells resembling those of T cell lymphoblastic lymphoma.
Metastatic Deposits:
Lymph nodes are commonly involved by metastatic cancer. Malignant melanoma, 
carcinomas and sarcomas exhibit a propensity to metastasize to lymph nodes. 
 Metastatic carcinoma becomes progressively more common with old age.
Cytology:
Berg (1961)8 identified the following circumstances that facilitate the diagnosis of 
lymph node metastases by FNAC
1. For confirmation of a secondary lesion in cases of known or an occult primary
2. For  diagnosis  of  a  secondary  lesion  during  follow  up  of  treated  primary 
malignancy.
3. Cases  with  clinical  diagnoses  other  than  metastatic 
lymphadenopathy.
4. For staging of malignancies.
FNA biopsy useful  in the diagnosis of metastatic malignancy, the diagnosis is 
usually easy, accurate and safe.29 
FNA  biopsy  has  a  lower  risk  of  subsequent  complications,  including  tumor 
recurrence, than histologic biopsy. FNA biopsy has also considerable value in staging 
the disease or documenting recurrence.66 
Anucleated squames may also appear as spindle shaped and tadpole shaped cells 
arranged in a “cell within cell” pattern.62 
  
Metastatic  adenocarcinomas  regardless  of  the  site  of  origin,  usually  contain 
tumour cells that are arranged singly or in cohesive groups of various sizes.62 
The presence of aggregates of tumour cell  with nuclear molding and extensive 
necrosis is characteristic of small cell carcinoma.62
Special  studies  such  as  electron  microscopy  or  immunocytochemistry  can  be 
applied to FNA biopsies if necessary, to assist in the differential diagnosis of tumour 
cells.25 
The highest diagnostic accuracy with FNA biopsy of lymphadenopathy is in the 
diagnosis of metastatic carcinoma.58
Histopathology:
The metastatic tumour often starts as isolated cellular clusters in the subcapsular 
sinuses, with gradual replacement of the nodal parenchyma.  This may be accompanied 
by a desmoplastic reaction or inflammatory reaction including granuloma formation.
The number and level of lymph nodes involved, the size of nodal deposit  and 
presence  or  absence  of  extra  capsular  extension  are  the  most  significant  prognostic 
factors.
Epithelial  elements  may  be  found  in  lymph  nodes  mimicking  metastatic 
carcinoma.  Salivary  gland  inclusions  are  commonly  found  within  intraparotid  and 
cervical lymph nodes.  Rarely, mammary inclusions occur within axillary lymph nodes. 
Thyroid follicle inclusions in cervical lymph nodes are very rare.45
 
Benign epithelial inclusions occurring in lymph nodes can be diagnosed by using 
uniform microscopic size, lack of cytologic atypia and lack of stromal reaction.
Metastatic cancer may be bland in appearance and mistaken for developmental 
lesions. For example, cystic metastasis from squamous cell carcinoma of the head and 
neck region or papillary thyroid carcinoma may mimic branchial cyst.13
Some  metastatic  carcinomas,  melanoma  and  germinoma  are  difficult  to 
distinguish from lymphoma.
Special  stains  such  as  reticulin  and  mucin  stains  are  sometimes  valuable  in 
differentiating the nature of a lymph node metastasis.
The reticulin fibrillar framework of lymphoid tissue becomes apparent and serves 
as a useful criterion to distinguish large cell lymphoma from metastatic undifferentiated 
carcinoma or melanoma.
A well developed, fine, branching, reticulin network with pericellular fibrils is 
characteristic  of  lymphoma,  whereas  thick  reticulin  fibers  with  an  alveolar  pattern 
surrounding nests and cords of cells are indicative of metastatic non-lymphoid tumours. 
Immunohistochemical studies for cytokeratin, CD45 (LCA) and S-100 protein are 
helpful  to  distinguish  epithelial  malignant  tumours  from  lymphoma.  However,  the 
occurrences of cytokeratin positive dentritic cells in lymph nodes are also possible.14 
    
The  accuracy  of  metastatic  carcinoma  reported  by  Gupta  et  al  (1977)41 and 
Tripathi et al (1985)121 were 90 percent and 80.25 percent respectively.
Kline  TS  et  al  (1984)57 reviewed  the  results  of  376  superficial  lymph nodes. 
Diagnosis  of  metastatic  carcinoma based  on “alien”  cells  and melanoma was  easily 
made with an accuracy of 95%
  
Haque MA et al43 studied 117 cases of FNAC lymph nodes in a period between 
November 2001 and April 2002 and pointed out that in the malignancy of lymph node, 
sensitivity and specificity of FNAC were 82.76% and 97.92% respectively.
Ustun M et al  (2002)124 pointed out that the most challenging lesions to assess 
using  FNAC  were  metastatic  lymph  nodes  showing  cystic  change  and   they  also 
suggested that  FNAC should be repeated in cases of  suspicious hypo cellular  cystic 
aspirates, especially in patients with known malignancy.
Tseng  FY  et  al  (2002)122 studied  the  cytological  characteristics  of  metastatic 
papillary thyroid carcinoma in cervical lymph nodes. In their study, they pointed out that 
metastatic papillary thyroid carcinoma in cervical lymph nodes had a higher frequency 
of cystic degeneration than intra thyroidal lesions. 
Cangiarella  et  al  (2000)12 described their  experience with aspiration biopsy  of 
metastatic melanoma in lymph nodes.  Except for one false positive error caused by 
dermatopathic  lymphadenopathy  and  two  false  negative  results  in  115  patients,  the 
results of FNA were in concordance with histopathology and clinical follow up data.
Ramzay I et al (1985)100 analyzed Fine needle aspiration biopsy of lymph nodes in 
350 patients and modified biopsy technique used in same patients. Of the 350 patients, 
209  aspirates  were  categorized  as  cytologically  malignant,  102  as  benign,  30  as 
suspicious for malignancy and 9 as unsatisfactory. Cervical Lymph nodes were most 
commonly sampled (58%), and supra clavicular nodes were most likely to be malignant 
(90%). The overall diagnostic accuracy achieved was 94%, one false positive and nine 
(2%)  false  negative  results  were   observed.   In  3%  of  the  30  cases  diagnosed  as 
suspicious  for  malignancy,  follow up open biopsy  of  the lymph nodes proved them 
benign.  They said that there were some possible sources of error, particularly in the 
diagnosis of lymphomas. 
Pilotti S et al (1993)96 studied 285 patients with enlarged superficial lymphnode 
and  demonstrated  high  rate  of  conclusive  cytologic  diagnoses  in  the  assessment  of 
metastatic malignancies, with an overall accuracy rate of 99.1% and a typing accuracy 
rate  of  96.5%.  They  also  pointed  out  that  Immunocytochemistry  appeared  to  be  of 
limited value in the distinction between centroblastic-centrocytic follicular lymphomas 
and  reactive  follicular  hyperplasia.  In  low  grade  NHL,  morphologic  and 
immunocytochemical  methods  need  to  be  supplemented  by  molecular  techniques  in 
order to achieve conclusive diagnoses. 
Lioe TF et al (1999)70 studied aspirate from 157patients with enlarged superficial 
lymph nodes which were obtained over a 5 year period in a combined surgical/FNAC. 
A definitive diagnosis was achieved in over 77% of the cases; benign 52% malignant 
25.1%; the diagnostic accuracy was 94.4%, sensitivity 85.4% and specificity 100%.  
Hema Arora (2000-01)46 studied 130 cases of superficial lymphadenopathy. In her 
study,  maximum number of  patients was in their  3rd and 4th decade.  Involvement of 
cervical lymphnodes were maximum (75%) followed by axillary (13%), supraclavicular 
(7.6%)  and  inguinal  (6.15%).  In  metastatic  lesion  of  lymph  nodes,  squamous  cell 
carcinoma was found to be maximum (71.42%) followed by adenocarcinoma (28.57%). 
   FNAC had an overall diagnostic accuracy in 69.56% of cases.  
Van de Schoot L et al (2001)125 retrospectively studied FNACs of 73 peripheral 
lymph  nodes  and  showed  92%  sensitivity  and  90%  specificity  respectively.  FNAC 
helped to avoid additional surgical diagnostic procedures in 86% of cases
Gupta RK et  al (2003)40 analyzed in 218 cases with enlarged lymph nodes by 
FNAC  and  histology.  They  pointed  out  that  the  overall  sensitivity  was  92.7% and 
specificity was 98.5 %.
Al-Mulhim AS (2004)1 studied 94 patients with lymphadenopathy and concluded 
that overall accuracy of FNAC was 93%.
MATERIAL AND METHODS
The  present  study  was  carried  out  in  the  Department  of  Pathology,  Madurai 
Medical College, Madurai, India for a period of 2 years from January 2004 to December 
2005.
The cytological materials were obtained in the form of smears, which were fixed 
in 95% alcohol for PAP and H&E staining.   The aspiration syringes used were 10-20ml 
and needle size between 22-23 gauges.
The specimens were received from Department of Surgery, Government Rajaji 
Hospital, Madurai.  Details of the patients such as clinical and personal history were 
recorded including details of operative findings, macroscopic and microscopic features. 
The working proforma is appended in the annexure I.
 The histopathology specimens were fixed in 10% buffered formal saline.  After 
paraffin embedding 5 micron thick   sections were made, stained with H&E48 and PAP48. 
Special stains such as Reticulin were used as and when required.  Immuno histochemical 
studies were done in relevant cases. (Annexure II) 
Photographs of the specimen, photomicrographs of the smears and sections were 
taken wherever needed.
The results of the lymph node were divided in the following diagnostic categories:
Reactive Lymphadenitis,Tuberculous Lymphadenitis, Lymphomas and metastatic 
deposits.
A suspicious report was issued when there were only few abnormal cell or cells 
lacking  the  majority  of  criteria  for  malignancy.   Specimens  were  considered 
unsatisfactory  when there  were  sparse  lymphoid  elements,  poor  cell  preservation  or 
much blood.
Due to nonavailability of routine Immunological studies,  Working Formulation 
has  been  followed  for  classification  of  Lymphomas.   Conversion  table  for  working 
formulation to WHO classification is shown in the annexure III. 
The results of both procedures were compared.
The formulae for assessing sensitivity and specificity are as follows:
Screening test results Diagnosis
Diseased Not Diseased
Total
Positive
Negative
a(True Positive)
c(False negative)
b(False Positive)
d(True negative)
a+b
c+d
Total a+c b+d a+b+c+d
The following measures are used to evaluate a screening:
Sensitivity= a/ (a+c) x100
Specificity=d/ (b+d) x100
Accuracy=a+d/ (a+b+c+d) x100
OBSERVATION AND RESULTS
In the two-year study period from Jan 2004 to Dec 2005, 10,506 general biopsy 
materials were received from Government Rajaji Hospital, Madurai.  Of these, Lymph 
node lesions accounted for  634 cases.   Hence,  the overall  incidence of  lymph node 
lesion in this hospital was 6.03%
The total numbers of benign lymph node lesions were 499. Out of these, reactive 
lymphadenitis  was  154  (24.3%)  and  tuberculous  lymphadenitis  was  342  (53.94%). 
Others  were  three  in  number  (0.47%)  (Kimura’s  disease-1,  Dermatopathic 
Lymphadenitis-1 and Lepromatous Lymphadenitis-1). Thus over all incidence of benign 
lesion was 78.7%
The  total  numbers  of  malignant  lesions  were  135.   Out  of  these,  metastatic 
deposits were 92 (14.15%), Lymphomas were 41 (6.46%) and Leukemia involving the 
Lymph node was two (0.32%).  Out of Lymphomas, Non Hodgkin’s lymphoma was 18 
and Hodgkin’s lymphoma was 23. Hence, overall  incidence of malignant lesion was 
21.3% (Diagram 1 & 2)
Age incidence:
  Benign lymph node lesions had peak age incidence in the second decade.
      The age incidence of lymphomas ranges from 4 to 80 years.  In that, Hodgkin’s 
lymphoma occurs in young  (from 4 years) as well  as in the old age (up to 79).  Non 
Hodgkin’s lymphoma commonly occurs in patients with age group of 40 to 80years. 
Secondary carcinomatous deposit was commonly encountered in persons of 40 to 70 
years.
The distribution of lymph node lesions according to age is shown in diagram 3.
Sex incidence:
       Out of the 499 benign lymph node lesions, 299 cases occurred in females (incidence 
59.9%), 200 cases occurred in males (incidence 40.1%). Hence, male to female ratio in 
benign conditions were 1:1.5.
      
Out of 92 patients with secondary carcinomatous deposits, 33cases were females 
(35.9 %), 59 cases were males (64.1%) and out of 41 cases with lymphomas 12 cases 
were females (29.7%) 29 cases were males (70.3%)
Node Enlargement:
    79.8  % of  the  patients  had  cervical  node  enlargement,  10.2% of  patients  had 
axillary node enlargement and only 5.7% of patients had inguinal  lymphadenopathy, 
followed by supraclavicular node enlargement, which was only 4.3 %.( Diagram 4)
Cytological evaluation of lymph node lesions:
During the study period, 388 smears were received for cytological examination. 
Out of these 87cases had post surgical follow-ups.  
Out of the 87 smears studied, 21 cases (24.1%) were reactive lymphadenitis(Fig 
1), 26 cases (29.9%) were Tuberculous lymphadenitis (Fig4), 6 cases (6.9%) were Non 
Hodgkin’s  Lymphoma  (Fig7,Fig9,Fig10  &Fig12),  3  cases(3.4%)  were  Hodgkin’s 
Lymphoma (Fig18), 30 cases (34.5%) were Metastatic deposits(Fig25,Fig26, Fig27,& 
Fig28) and one case was (1.2%) found to be unsatisfactory. (Table 1)
 The  commonest  non-neoplastic  lesion  encountered  was  tuberculous 
lymphadenitis.  The  most  common  malignant  lesion  diagnosed  was  metastatic 
carcinomatous deposits.
Histopathological Diagnosis:
The histopathological diagnosis offered for the 87 cases is shown in table2.  Out 
of the 87 cases 20 cases (23%) were reactive lymphadenitis(Fig2),29 cases (33.3%) were 
Tuberculous  lymphadenitis  (Fig5),  4  cases  (4.6%)  were  Non  Hodgkin’s  Lymphoma 
(Fig8&Fig11) , 4 cases (4.6%) were Hodgkin’s Lymphoma (Fig19), one  case (1.2%) 
was  Leukemia  involving  the  lymph  node  (Fig22)  and  29  cases  (33.33%)   were 
metastatic deposits.(Fig29&30) 
The  most  common  non-neoplastic  lesion  encountered  was  tuberculous 
lymphadenitis.  Among  the  malignant  lesion,  most  common  was  metastatic 
carcinomatous deposits.
Correlation between cytological and histopathlogical diagnosis:
Out of the 21 smears of reactive lymphadenitis, 18 were diagnosed as reactive 
lymphadenitis by histopathology, 2 were diagnosed as tuberculous lymphadenitis, and 
one case was diagnosed as Hodgkin’s Lymphoma.  All the 26 smears of tuberculous 
lymphadenitis were confirmed by histopathology. 
Out of 6 smears of Non Hodgkin’s Lymphoma, only 4 cases were diagnosed by 
histopathology, one case turned out to be a reactive lymphadenitis and one case was 
turned out to be a Leukemia involving the lymph node. All the 3 smears of Hodgkin’s 
Lymphoma were confirmed by Hodgkin’s Lymphoma by histopathology.  Out of 30 
smears of metastatic deposits, 29 were diagnosed as same by histopathology and one 
was diagnosed as reactive lymphadenitis.
There was an excellent correlation in cases of tuberculous lymphadenitis (100%) 
and Hodgkins Lymphoma (100%).
Table  3  illustrates  the  correlation  obtained  between  cytological  and 
histopathological diagnosis.
Sensitivity and Specificity:
Reactive Lymphadenitis:
Out of 21cases, which were diagnosed cytologically as reactive lymphadenitis, 18 
cases turned out to be reactive process (True Positive-18) and 2 cases were tuberculous 
lymphadenitis and one case turned out to be a Hodgkin’s Lymphoma. (False Positive-3) 
The sensitivity of FNAC in diagnosing reactive lymphadenitis was found to be 90%. 
One case, which was diagnosed as metastatic deposits and other case that was diagnosed 
cytologically as lymphoma turned out to be a reactive lymphadenitis histopathologically. 
Hence, specificity for this lesion is 95.6% and accuracy was 93.1%.
Tuberculous Lymphadenitis:
     26 cases, which were diagnosed as tuberculous lymphadenitis cytologically were 
confirmed by histopathology also. (True Positive-26). Two cases, which were diagnosed 
as reactive lymphadenitis cytologically, turned out to be tuberculous in histopathology 
(False Negative-2).  The sensitivity, specificity and accuracy rates were 92.8%, 100%, 
and 96.5% respectively.
Non-Hodgkin’s Lymphoma:
Out of 6 cases diagnosed cytologically, only 4 were confirmed by histopathology 
(True Positive-4).  One case turned out to be a Leukemia involving the lymph node and 
other  turned  out  to  be  a  reactive  lymphadenitis.  The  sensitivity  of  Non-Hodgkin’s 
Lymphoma was 100%, the specificity was 97.5%, and accuracy was 97.7%. 
 3 out of 4 cases had bone marrow involvement.
Immunohistochemical staining showed positive for CD20 in three cases of Non 
Hodgkin’s Lymphoma.(Fig16&Fig17) 
Hodgkin’s Lymphoma:
Only 3 cases were diagnosed cytologically as Hodgkin’s Lymphoma, and all the 
three cases were confirmed histopathologically also (True Positive-3).  However,  one 
case which was diagnosed histopathologically as Hodgkin’s was diagnosed cytologically 
as  reactive  lymphadenitis  (False  negative-1).  Hence,  the  sensitivity  of  FNAC  in 
Hodgkin’s  Lymphoma  was  75%,  whereas  specificity  was  100%  and  accuracy  was 
98.6%.
Immunohistochemical  markers  CD15  and  CD30  were  positive  in  a  case  of 
Hodgkin’s Lymphoma mixed cellularity type.(Fig20&Fig21)
Metastatic Deposits:
    Out of 30 cases diagnosed as metastatic deposits cytologically, 29 cases were 
confirmed histopathologically  (True Positive-29),  One case turned out  to be reactive 
Lymphadenitis (False Positive-1).  The sensitivity of metastatic deposits by FNAC is 
100%, specificity was 98.2%, and accuracy was 98.8%.
Thus,  overall  sensitivity,  specificity  and  accuracy  of  F.N.A.C  in  superficial 
lymphadenopathy were 91.6 %, 98.3%, 97 % respectively.
The details of sensitivity, specificity and accuracy of each lesion were illustrated 
in Table 4. 
  
     DISCUSSION
 The recent trend in medical practice is toward adopting a diagnostic modality, 
which is both cost effective and minimally invasive.  In this regard, FNAC is often used 
as  a  first  line  of  investigation  for  screening cases  with lymphadenopathy,  since  this 
method  is  easy  to  perform,  rapid,  and  inexpensive.  FNAC  can  help  not  only  to 
differentiate among lymphoma, and metastasis, but also to identify nonspecific reactive 
lymphadenitis and specific infections such as tuberculous lymphadenitis. 
Age Incidence:
 In our study the age of the patients ranged between 3 and 70 years. (Diagram 2). 
The peak age incidence of non-neoplastic lymph node lesions were found to be in 
the second decade.
For metastatic lesions, the age ranged from 40 to 80 years, whereas lymphomas 
had bimodal peak at second and seventh decade. 
Sex Incidence:
In the present study the male to female ratio was1: 1.5   
Site of Swelling: 
Involvement  of  cervical  lymph  nodes  were  maximum  (79.8  %)  followed  by 
axillary (10.2%), inguinal (5.7%), and supraclavicular node (4.3%)
A similar  incidence had been quoted by Kline et  al  (1984)57 and Hema Arora 
(2001)46. (Table 5) 
Reactive Lymphadenitis:
The cytological  features  of reactive lymphadenitis  revealed  cellular  specimens 
composed of  small  lymphocytes predominated with a  few neutrophils,  plasma cells, 
histiocytes elongated fibroblasts and phagocytes. (Fig 1)
 Grossly the affected lymph nodes were enlarged and firm.  Histo pathologically 
reactive lymphadenitis showed follicular, sinus, or mixed patterns.
          In  follicular  hyperplasia,  histopathological  examination  showed  marked 
enlargement and prominence of the germinal centers.  (Fig 2)   
The  results  of  this  work  indicate  that  benign  lymphadenopathy  constitutes  a 
significant proportion of findings in aspirates of enlarged lymph nodes (55.3%). It was 
also  proved  that  cytological  examination  may  not  only  help  to  distinguish  between 
benign and malignant types, but may also suggest the nature of the benign process.   Out 
of non-neoplastic lymph node  lesions which formed 55.3%, the second most common 
diagnosis was reactive hyperplasia, which was second to the incidence of tuberculosis in 
the present study. This figure is correlating with the study of Bezabih M et al (2003)9
          One case, which was diagnosed as metastatic deposits, and other case that was 
diagnosed as lymphoma by cytology were turned out  to be a reactive lymphadenitis 
(False Negative -2).  These errors were made because of cell with large nucleoli.  Some 
were histiocytes, later recognized because of its size and chromatin pattern.  Others, 
immature  lymphocytes  from  the  germinal  centers,  still  have  potential  for  causing 
misdiagnosis.  Errors can be diminished by noting surrounding benign polymorphic cells 
and occasional phagocytes.
   The sensitivity of diagnosing reactive lymphadenitis is 90% 
Tuberculous lymphadenitis:
The  cytological  diagnosis  of  tuberculous  lymphadenitis  was  made  definitely, 
when granulomas composed of epithelioid cells and Langhans’ cells are seen. (Fig 4) but 
even in the absence of granulomas, necrosis along with the presence of lymphocytes 
alone gives an indirect evidence of tuberculous lymphadenitis.
 Grossly the affected lymph nodes are matted and showed caseous necrosis. (Fig3)
Histopathological  examination  of  tuberculous  lymphadenitis  showed  caseous 
necrosis, epithelioid cell granulomas and Langhans’ giant cells. (Fig5)  
In the present study, the sensitivity for tuberculous lymphadenitis is 92.8%. Two 
cases of tuberculous lymphadenitis diagnosed as reactive lymphadenitis on cytological 
examination  were  subsequently  found  to  be  tuberculous  lymphadenitis  in 
histopathology. Probably, the representative samples were  not obtained in these cases. 
The diagnostic   accuracy  in  the  present  study  is  96.5%.   This  is  higher  than 
accuracy rate of other research workers.  The success result  of FNAC in tuberculous 
lymphadenitis by other research workers were 80% (Bloch, 1967)10; 87.18% (Patra et al, 
1983)93; and 83.33% (Dandapat et al, 1986)17. 
Lymphoma:
Non Hodgkin’s Lymphoma
Cytological  criteria  for  diagnosing  Non  Hodgkin’s  Lymphoma  were 
monomorphism and macronuleoli. ( Fig7, Fig9,Fig10& Fig12) 
Although sub classification was attempted, the aim was to distinguish lymphoma 
from hyperplasia.
Grossly cut surface of enlarged lymph node showed gray white and fish flesh 
appearance. (Fig6)
Histopathological examination of Small Lymphocytic Lymphoma shows loss of 
architecture and replaced by diffuse proliferation of well differentiated, mature, small 
and uniform lymphocytes without cytologic atypia or significant mitoses. (Fig8)
Histopathologically  Diffuse  Large  cell  Lymphoma   have  diffuse  pattern  of 
involvement by large cells showing round to oval nucleus and two to three nucleoli, with 
increased mitotic activity. (Fig11) 
In a case of (2946/05) Non Hodgkin’s Lymphoma perinodal fatty infiltration was 
seen.  ( Fig13)
Reticulin stain in a case of Non Hodgkin’s Lymphoma showed a  fine, branching 
reticulin network with pericellular fibrils characterize the lymphoma.  ( Fig 15)
Peripheral smear showed atypical Lymphoid cells with clefting of the nucleus. 
( Fig14)
Immuno histochemically three of Non Hodgkin’s Lymphoma cases showed CD 
20 positivity.  (Fig16 &Fig17) 
The diagnostic accuracy of Non Hodgkin’s lymphoma is 97.7% Aspirate of one 
patient was false-positively interpreted as lymphoma, who had a corresponding biopsy 
showing reactive hyperplasia.  This error was made because of the presence of a few 
cells with large nucleoli.  Some of these cells were histiocytes and others were immature 
lymphocytes from the germinal centers. Lee et al also found difficult in differentiating 
between reactive hyperplasia and lymphoma by cytology alone.
Hodgkin’s Lymphoma:
In  Hodgkin’s  lymphoma,  the  main  cytological  feature  was  polymorphism 
constituted by immature lymphocytes, eosinophils and Reed-Sternberg cells. (Fig18)
Grossly  the  cut  surface  of  Hodgkin’s  lymphoma  showed  nodular  scarring  in 
nodular sclerosis type whereas mixed cellularity type showed abundance of necrosis. 
On microscopic examination of nodular sclerosis type of Hodgkin’s lymphoma 
showed variable amount of fibrous tissue and characteristic lacunar type of RS cells. 
(Fig19)
Immuno histochemical markers CD15 and CD 30 were positive in a case of 
Hodgkin’s Lymphoma mixed cellularity type. (Fig20&Fig21)
The diagnostic accuracy of Hodgkin’s lymphma is 98.8%.  One case was 
diagnosed as reactive lymphadenitis in cytology, but showed Hodgkin’s lymphoma in 
histopathology. This may be due to absence of Reed-Sternberg cells in the cytology 
smears.
During the study period, one case was diagnosed histopathologically as reactive 
lymphadenitis.  After  six  months,  the  same  case  was  rediagnosed  as  suggestive  of 
Hodgkin’s Lymphoma cytologically and that was confirmed by histopathology also. 
            In False negative cases, it may be necessary to repeat FNAC studies, if there is 
strong  clinical  suspicious  of  neoplasm.   Sometimes  False  negative  results  can  be 
encountered due to small or inaccessible nodes, fibrosis, necrosis or sampling the wrong 
node.
 
              Gupta et  al  (1977)41 who exclusively  studied aspiration smears  of  lymphoma 
cases also mentioned the possibility of overlap among reactive hyperplasia, lymphocytic 
lymphoma and Hodgkin’s disease.
      
  Gupta et al (1977)41, Tripathi et al (1985)121, Mondal et al (1989)81 and Al-Muhim et 
al(2004)1 quoted the diagnostic accuracy in lymphoma as 84%, 80%,96.2% and 88% 
respectively. In the present study, the diagnostic accuracy was 97.7%. 
Leukaemia involving Lymph node: 
Histopathologically Acute Lymphoblastic Leukaemia involving the lymph node 
was appearing to begin at the center of the node residual lymph node structure was seen 
at the periphery. (Fig 22)
One case was reported as suggestive of lymphoma in F.NAC, tissue section of the 
same lymph node when correlated  with  blood smear  findings,  revealed  evidence  of 
leukemia involving the lymph node. In such cases, it is very difficult to differentiate 
between  Non-Hodgkin's  lymphoma  and  leukemic  infiltration  on  the  examination  of 
cytological smears alone.  Hence, in all cases of suspected lymphoma, details regarding 
haematological  and smear  findings  and marrow features  are  essential  for  correlative 
study.    
Metastatic Deposits:
          The FNAC from metastatic carcinoma was cell rich chiefly with cells foreign to 
lymph nodes, but occasionally, intermingled with lymphoid cells.  Specific primary site 
identification was accurate in many cases.
 
Cells from squamous cell carcinoma, papillary adeno carcinoma and malignant 
melanoma were the easiest to identify.  Cells from squamous cell carcinoma were single, 
pleomorphic and had abundant homogeneous keratinized cytoplasm with central nuclei. 
(Fig25)
  Papillary  clusters,  intranuclear  clear  areas  and rare  psammoma bodies  were 
characteristic  features  of  papillary  thyroid  carcinoma.(Fig27)   Metastatic  melanoma 
showed features of isolated oval cells, two or three distinct cell populations based on cell 
size, multinucleation,  macro nucleoli, and intra nuclear inclusions.(Fig26)
Grossly  metastatic  deposits  of  malignant  melanoma showed brownish melanin 
pigment  deposits.  (Fig24)  Metastatic  deposits  of  squamous  cell  carcinoma  showed 
grayish white tumour areas. (Fig23)
Histopathologically, in malignant melanoma lymph node was partially replaced 
by melanoma cells showing marked pleomorphism and prominent melanin pigments. 
(Fig 29)
 Reticulin  stain  of  squamous  cell  carcinoma  showed  thick  reticulin  fibres 
surrounding the cords and islands of carcinoma cells.  (Fig30)
   
During  the  study  period,  metastatic  squamous  cell  carcinoma  was  found  in 
maximum number (41.3%) followed by adenocarcinoma (27.6%).  This is correlating 
with the study of Hema arora et al.46 
In  the  present  study  the  accuracy  rate  of  diagnosing  metastatic  carcinoma  is 
98.8% It is higher than the accuracy reported by Gupta et al (90%)41  and Tripathi et al 
(80.2%)121.  
In the present  study overall  sensitivity, specificity and accuracy of F.N.A.C in 
superficial lymphadenopathy were 91.6 %, 98.3%, 97 % respectively.
Table 6 shows  the comparative study of sensitivity, specificity and accuracy of 
F.N.A.C in superficial lymphadenopathy with various studies.
Table  7  shows  the  comparative  study  of  accuracy  of  individual  lesions  with 
various authors.
SUMMARY
The  study,  FNAC  of  Lymph  node  lesions  with  subsequent  correlation  of 
histopathology revealed the following findings.
1. Of the 10,506 general biopsy materials received from Government Rajaji Hospital 
Madurai  during the study period (January 2004 – December  2005),  634 cases of 
lymph node lesions were encountered with the incidence of 6.03%.
2. During the study period, 388 smears were received for cytological examination. 
3. Out of 388 smears, 87 had histopathological correlation.
4. The peak age incidence of non- neoplastic lymph node lesions was in the second 
decade.
5. Hodgkin’s lymphoma occurs in young (4 -30), and old age (45 -79).
6. Non Hodgkin’s lymphoma and metastatic deposits commonly occur in the old age.
7. Common site of Lymph node enlargement was cervical group.
8. The  most  common  Non  neoplastic  lesion  in  the  present  study  was  tuberculous 
lymphadenitis accounting for 29.9% cytologically and 33.3% histopathologically.
9. Among  the  malignant  lesion,  the  incidence  of  metastatic  deposits  was  high  and 
accounting for 34.5% cytologically and 33.33% histopathologically.
10. Among the metastatic deposits, squamous cell carcinoma was the commonest one.
11.Among  the  non  neoplastic  lesion  tuberculous  lymphadenitis  had  excellent 
correlation.
12.Three out of 4 cases of Non Hodgkin’s lymphoma had bone marrow involvement.
13.Immunohistochemically  three  cases  of  Non Hodgkin’s  Lymphoma showed CD20 
positivity.
14. The sensitivity, specificity and accuracy rates of reactive lymphadenitis were 90%, 
95.6% and 93.1% respectively.
15. For  tuberculous  lymphadenitis  sensitivity  was  92.8%,  specificity  was  100%  and 
accuracy was 96.5%. 
16.The sensitivity of Non Hodgkin’s Lymphoma was 100%, the specificity was 97.5%, 
and accuracy was 97.7%.
17.The  sensitivity  of  Hodgkins  Lymphoma  was  75%,  specificity  was  100%,  and 
accuracy was 98.6%.
18. The sensitivity,  specificity,  and accuracy rates of metastatic  deposits were 100%, 
98.2%, and 98.8%.
19. The  overall  sensitivity  for  F.N.A.C.  of  superficial  lymphadenopathy  was  91.6%, 
specificity was 98.3%, and accuracy was 97%.          
CONCLUSION
In summary, “a correlative cytological and histopathological study on superficial 
lymphadenopathy” revealed the overall  sensitivity was 91.6%, specificity was 98.3% 
and accuracy was 97%.   False positive and false negative reports can be minimized by 
sampling appropriate nodes and by correlative haematologic study.
The  results  are  quite  encouraging  and  FNAC  is  recommended  as  the  initial 
diagnostic test in the evaluation of superficial lymphadenopathy.  Although FNAC has 
proven  to  be  a  simple,  safe,  reliable  and  cost  effective  diagnostic  tool  for 
lymphadenopathies, the limitation of the procedure should be kept in mind and excision 
biopsy should be used whenever required.
       Immunohistochemical staining is useful for confirmation of diagnosis in nodal 
lesions especially lymphoma and for further classification of lymphomas.
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ANNEXURE -I
PROFORMA
NAME:                             AGE:               SEX:
OCCUPATION: OP/IP NO: UNIT:
CY NO: HPE NO:
CLINICAL SYMPTOMS:
SWELLING: SITE:  Cervical / Axillary / Inguinal / Supraclavicular / Others 
            Duration:
FEVER: Intermittent / Evening rise of Temperature
ANY OTHER SWELLING:
PAST H/O TB: Present /Absent 
ON EXAMINATION:
SWELLING: Site:
                      Size:
                      Consistency: Firm / Hard
                      Matted / Discrete 
                      Mobile/ Fixed                 
        
ANY OTHER SWELLING:
LIVER: Palpable / not Palpable           If Palpable……………….cm below Right costal   
                margin
SPLEEN: Palpable / not Palpable  If Palpable……………….cm below Left costal 
 margin
       
F.N.A.C:
Cellular / Acellular
Monotonous / Varying population
Epithelioid cells: Present / Absent
Giant cells:   Langhan type / other types
R.S. Cells: Present/Absent
Background cells: Lymphocytes / Histiocytes / Eosinophils / Plasma cells / Neutrophils / 
      Tingible body macrophages
Mitotic Activity: Present / Absent
Necrosis: Present /Absent
Metastatic Deposits: Present / Absent
Type of Tumour cells: Squamous cell carcinoma /Adeno carcinoma / 
 Papillary carcinoma/ Malignant melanoma 
Cytological Diagnosis:
Histological Data:
Gross appearance                                                        :   
Microscopic appearance                                             :
Diagnosis offered                                                        :
Comments and Remarks:
Investigations:
TC, DC, ESR:
Peripheral Smear & Bone marrow:
Immunohistochemistry:
ANNEXURE –II                                                                        
PROCEDURES FOR SPECIAL STAINING 
    I. RETICULIN STAIN48
1. Bring sections to water.
2. Treat with  potassium permanganate solution for 1-2 minutes.
3. Wash in water, bleach with the potassium metabisulphite solution.  Wash well in 
water. 
4. Treat with the iron alum solution for 1 minute.Wash well in tap and then distilled 
water.
5. Treat with ammonical silver solution for 1 minute.
6. Wash briefly in distilled water and reduce in 10%formalin for 3 minutes.
7. Wash, then tone in 0.2% gold chloride for up to 10 minutes.
8. Rinse in distilled water, then treat with the potassium metabisulphite      solution 
for 1minute.
9. Rinse with distilled water and fix with 5% hypo for 1-2 minutes.
10.Wash, dehydrate, clear, and mount in D.P.X..
Results: 
            Reticulin fibres         ……………         Black
            Nuclei                       ……………         grey 
            Collagen                   ……………         grey-purple
            
IMMUNO HISTOCHEMICAL STAINING 48
1. Sections to alcohol.
2. Block  endogenous  peroxidase  activity  by  incubating  in  hydrogen  peroxide 
solution for 30 minutes.
3. Hydrate sections by passing through graded ethanol series and wash in running 
water for 15 minutes.
4. Incubate sections in the normal swine serum diluted in Tris/saline for 15 minutes. 
5. Drain off excess Tris-buffered normal swine serum.
6. Incubate sections with primary antiserum diluted 1:2000, 1:1000, 1:250 and 1:100 
in 1%normal swine serum for 30 minutes.
7. Jet wash off excess antiserum and then wash slides in Tris / saline for three 2 
minutes changes.
8. Incubate sections in swine anti-rabbit IgG diluted 1:20 for 30 minutes.
9. Jet wash off excess antiserum and then wash slides for three 2 minutes changes.
10.Incubate sections in PAP complex diluted 1:60 in 1% normal  swine serum in 
Tris / saline for 30 minutes.
11.Jet wash off excess complex and wash in Tris / saline for three 2 minutes changes.
12.Incubate sections in DAB medium for 5 minutes.
13.Wash sections in running water for 10 minutes.
14.Counterstain in alum haematoxylin, dehydrate, clear and mount.
Results:
Reaction product          ……             brown
Nuclei                           ……             blue
ANNEXURE III
Conversion table for the terminology in the updated REAL / WHO classification13
                                                     ANNEXURE -IV
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